Dechra Pharmaceuticals PLC (OTCPK:DPHAY) ADRs soared 45% after the company confirmed it was in talks with EQT in regard to a potential all-cash 4.63 billion pound ($5.8 billion) offer the UK-based ...

Dechra, a global leader in veterinary specialty care, today announced the FDA approval of Zygolide ® (pergolide tablets), the ...

Update 7:20am: Adds deal confirmation, financing details. EQT AB agreed to purchase veterinary medicine company Dechra Pharmaceuticals (OTCPK:DPHAY) for £4.46 billion ($5.6 billion). Dechra shares ...

Dechra Pharmaceuticals (LON: DPH) (OTC: DCHPF) shares are going to rise strongly at the opening as the EQT bid is now negotiated and agreed. There is most unlikely to be any further fun to be had ...

U.K.-based Dechra Pharmaceuticals has spent much of the last year rolling out a global expansion plan that's largely focused on increasing its presence in North America, while also gaining a foothold ...

The U.K.’s Dechra Pharmaceuticals has been on an acquisition binge over the last year, picking up Croatian poultry vaccine maker Genara for $56.4 million, family-owned veterinary drugmaker ...

- International veterinary medicine group Dechra and ILC Therapeutics to develop ILC’s Caniferon product to treat atopic dermatitis in dogs BIOCITY, MOTHERWELL, Scotland--(BUSINESS WIRE)--Scottish ...

As of May 10, 2023, the average one-year price target for Dechra Pharmaceuticals is 4,017.32. The forecasts range from a low of 2,878.50 to a high of $5,250.00. The average price target represents an ...

(RTTNews) - Dechra Pharmaceuticals Plc. (DPH.L) Friday said it reached agreement to be acquired by Freya Bidco Limited for 3,875 pence per share in cash. The deal values Dechra at approximately 4.46 ...

Dechra Pharmaceuticals has agreed to conditionally acquire the entire issued share capital of Eurovet Animal Health, a vetinary pharmaceuticals business. The business will be purchased for €135m ...

Dechra Pharmaceuticals PLC is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; ...

As pandemic restrictions ease in some countries, the lockdown love for pets might also be on the wane. Dechra Pharmaceuticals slumped as much as 10 percent in London Monday, the most since 2018, after ...